You are here

  • Home
  • Archive
  • Volume 65, Issue 2
  • Management of acute-on-chronic liver failure: rotational thromboelastometry may reduce substitution of coagulation factors in liver cirrhosis

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Management of acute-on-chronic liver failure: rotational thromboelastometry may reduce substitution of coagulation factors in liver cirrhosis
  1. Sotiria Bedreli1,
  2. Jan-Peter Sowa1,
  3. Guido Gerken1,
  4. Fuat Hakan Saner2,
  5. Ali Canbay1
  1. 1 Department of Gastroenterology and Hepatology, University Hospital, University Duisburg-Essen, Essen, Germany
  2. 2 Department of General, Visceral and Transplantation Surgery, University Hospital, University Duisburg-Essen, Essen, Germany
  1. Correspondence to Professor Ali Canbay, Department of Gastroenterology and Hepatology, University Hospital, University Duisburg-Essen, Hufelandstr. 55, Essen 45122, Germany; ali.canbay{at}uni-due.de

https://doi.org/10.1136/gutjnl-2015-309922

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    With great interest we have read the manuscript by Angeli et al,1 demonstrating development of acute-on-chronic liver failure (ACLF) as an accurate predictor for mortality in hospitalised patients with decompensated liver cirrhosis. The authors show that assessment of the chronic liver failure-sequential organ failure assessment (CLIF-SOFA) score improves prognostic accuracy and is superior to the acute kidney injury (AKI) classification, when taken at 48 h after hospitalisation. Patients with acutely decompensated cirrhosis are in a severe condition and the manuscript shows that mortality is extremely high in patients with ACLF grade 3 (three or more organ failures). In a previous study, Reiberger et al 2 showed that therapy with β-blockers for variceal bleedings can effectively reduce decompensation of liver cirrhosis. Though, not all patients respond to this treatment. We would like to add a small contribution, which may improve management of these difficult to treat patients at high risk.

    One major difficulty in clinical management of patients with cirrhosis is impaired coagulation …

    View Full Text

    Footnotes

    • Contributors SB designed the study, acquired, analysed and interpreted data, and drafted the manuscript. J-PS analysed and interpreted data, and revised the manuscript for important intellectual content. GG and FHS acquired and interpreted data, and revised the manuscript for important intellectual content. AC designed the study, interpreted data and revised the manuscript for important intellectual content. All authors have approved the final submitted version.

    • Competing interests SB, J-PS, GG, FHS and AC declare that they have no competing interests in the research.

    • Ethics approval Ethikkommission am Universitätsklinikum Essen.

    • Provenance and peer review Not commissioned; internally peer reviewed.